Por: RTTNews Health December 19, 2022
The U.S. Food and Drug Administration has approved Ferring Pharmaceuticals A/S's Adstiladrin (nadofaragene firadenovec-vncg) to treat high-risk, non-muscle-invasive bladder cancer.Adstiladrin is a non-replicating, i.e., cannot multiply in human cells, adenoviral vector based gene therapy indicated for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC) with... + full article
Forbes USA Tech December 06, 2022
3D illustration of a virus infection (coronavirus, viral pneumonia or influenza) and the risks of ... [+] complications for the urinary system (kidneys,bladder,ureter). Front view. Isolated on black background. getty A new finds that symptomatic Covid-19 infection is associated... + más
How Bladder Cancer Differs By Age and Sex | Time
Bladder Cancer Can Be Tough on Mental Health. Here's How to Cope | Time
ABC News USA Health November 23, 2022
WASHINGTON -- U.S. regulators on Tuesday approved the first gene therapy for hemophilia, a $3.5 million one-time treatment for the blood-clotting disorder.The Food and Drug Administration cleared Hemgenix, an IV treatment for adults with hemophilia B, the less common form of the... + más
FDA approves most expensive drug ever, $3.5 million-per-dose gene therapy for hemophilia B | CBS News
$3.5M gene therapy for hemophilia gets FDA approval | WPLG Local 10
WPLG Local 10 USA Health November 23, 2022
WASHINGTON – U.S. health regulators on Tuesday approved the first gene therapy for hemophilia, a $3.5 million one-time treatment for the blood-clotting disorder.The Food and Drug Administration cleared Hemgenix, an IV treatment for adults with hemophilia B, the less common... + más
$3.5M gene therapy for hemophilia gets FDA approval | ABC News
CBS News USA Health November 23, 2022
Washington — U.S. health regulators on Tuesday approved the first gene therapy for hemophilia, a $3.5 million one-time treatment for the blood-clotting disorder. The Food and Drug Administration cleared Hemgenix, an IV treatment for adults with hemophilia B, the less common... + más
Time USA Health November 19, 2022
Although Mac Howard has spent the last 16 years without a , he never feels truly free. The 58-year-old Indiana resident still studies his urine for any traces of blood, and every time he marks another anniversary of his diagnosis, there’s a twist of fear in his stomach.... + más
FDA Approves First Gene Therapy For High-Risk, Non-Muscle-Invasive Bladder Cancer | RTTNews
Time USA Health November 16, 2022
Bladder cancer is one of the most commonly diagnosed forms of cancer in the U.S. About 1 in 40 Americans born today will develop this cancer at some point in their lifetime, and a majority of these people will be males over the age of 60. is the fourth most common cancer in... + más
Man gets jump-rope stuck in bladder after shoving it into his penis | New York Post
New York Post USA Life November 15, 2022
He should have skipped this jump rope. A 79-year-old Japanese man managed to get a 90-inch jump-rope stuck in his bladder after allegedly shoving the rope into his penis. Doctors wrote in published in Urology Case Reports that the unidentified man inserted the rope through his... + más
I was rejected from a job because my penis is too big | New York Post
About iurex | Privacy Policy | Disclaimer |